Castle Biosciences, Inc. (CSTL) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET. Company Participants. Camilla Zuckero - VP, IR and Corporate Affairs Derek Ma ...
Innovation Works' AlphaLab unveils first unified cohort
Innovation Works' AlphaLab accelerator named its first ever unified cohort. Selected companies will receive up to $100,000 in ...
Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus
Phase 1a study will evaluate single and multiple ascending doses of ABI-6250 in healthy participants with data expected in Q3 2025 –– Biomarker ...
Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock
Pacific Biosciences' Q4'24 results missed estimates. Growth in genetic data usage noted, but research funding uncertainties ...
EXCLUSIVE: Non-Hallucinogenic Psychedelic Compounds Show Promise For Treating Addiction And ADHD
Enveric Biosciences secures a U.S. patent for non-hallucinogenic mescaline derivatives targeting addiction, ADHD and anxiety.
Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Small-Cap Growth Stock to Buy Now?
We recently published a list of 10 Best Small-Cap Growth Stocks to Buy Now. In this article, we are going to take a look at ...
FT Vest SMID Rising Dividend Achievers Target Income ETF declares $0.1569 dividend
FT Vest SMID Rising Dividend Achievers Target Income ETF (BATS:SDVD) declares $0.1569/share monthly dividend. Forward yield 8.61% Payable Feb. 28; for shareholders of record Feb. 21; ex-div Feb. 21.